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IRRADIATION of C57B1 mice induced a high incidence of lymphatic leukaemia,
while being refractory to the spontaneous development of the disease. Several
investigators have isolated a leukaemogenic agent from these radiation-induced
tumours, which produces lymphoid leukaemia when injected into isologous new-
born or young adult non-irradiated mice (Lieberman and Kaplan, 1959; Latarjet
and Duplan, 1962; Laznicka and Smetanova, 1963; Ilbery and Winn, 1964).
It has been assumed that the leukaemogenic agent is present during post-natal
life in non-irradiated C57B1 mice, and that ionizing irradiation causes the release of
a leukaemogenic agent, in addition to thymus and bone marrow injury, which are
essential factors in radiation leukaemogenesis (Kaplan, 1964). Experimental
support for this hypothesis was provided by demonstrating the presence of a
leukaemogenic agent, for a limited period after completion of the irradiation
treatment, in centrifugates prepared from pooled, irradiated, non-]eukaemic
thymus and bone marrow (Haran-Ghera, 1966).
The aim of the present studies was to isolate a leukaemogenic filtrate from
normal tissues ofyoung and old mice, as well as to verify the radiation " release "
phenomenon (using more critical methods for the preparation ofthe leukaemogenic
agent, namely cell-free filtrates instead of the cell-free centrifugates tested in the
previous studies), to elucidate its time limitation, and to determine in which of
several different tissues the agent could be found.
A possible explanation for the " agent release " phenomenon, and its demon-
stration for a limited period of 5-10 days after completion of fractionated whole-
body irradiation, could be the transient variable depression of immunologic
responsiveness as a consequence ofthe irradiation. The immune reactivity ofthe
irradiated mice was therefore tested, using the Shigella antigen, and by evaluating
its capacity to elicit antibody production (agglutinating antibody to Shigella).
The degree and duration of immune depression of the host may influence the
amount ofagent released, which couldultimately be one ofthe contributing factors
in the lymphoma incidence rate in irradiated mice. Immune reactivity was
accordingly tested in mice treated by different procedures that are known to
prevent or enhance leukaemia development, e.g. bone marrow shielding or injection
of bone marrow cells shortly after the termination of irradiation, to decrease the
leukaemia incidence (Kaplan, Brown and Paull, 1953), and simultaneous treatment
with irradiation and urethane (Kawamoto et al., 1958), to increase the incidence
and shorten the latency of the disease. It has been shown that the protective
effect upon leukaemia induction of bone marrow shielding was nullified when theRADIATION IN LEUKAEMOGENESIS. I
mice were anaesthetized with urethane during the irradiation (Kawamoto et al.,
1958). The immunological reactivity of such treated mice was also tested.
The possibility that the reduced incidence of lymphomas brought about by
bone marrow shielding might be related also to a decreased " release " ofthe agent
was tested indirectly by attempting to modify the leukaemia incidence in bone
marrow shielded mice, through implantation of bone marrow taken from donor
mice that had been treated concurrently with X-rays and urethane, a procedure
shown to potentiate the activity of the leukaemogenic agent in bone marrow
(Haran-Ghera, 1966).
MATERIALS AND METHODS
Animals
Isogenic male and female C57B1/6 mice, 5-7 weeks old, originally derived from
the Jackson Laboratory, Bar Harbor, Maine, and subsequently maintained in our
Animal Breeding Centre by brother x sister mating, were used for this investiga-
tion. The mice were fed Purina Laboratory Chow, and provided wih tap water
ad libitum. They were kept in stainless steel cages bedded with sawdust, and
housed in an air-conditioned room at 21-25° C.
X-irradiation
The mice employed as donors for the irradiated tissues received 4 weekly doses
of 170 R whole-body exposure. The filtrable leukaemogenic agent was tested in
thymectomized mice exposed to 550 R whole-body irradiation and thereafter
implanted with a newborn thymus under the kidney capsule (Haran-Ghera, 1966).
The animals tested for immunological reactivity following irradiation received
4 exposures of 170 R each, either whole-body or with the thigh shielded at each
exposure or only during the last. Irradiation was performed with a General
Electric Maximar 250-III machine (physical conditions: 250 kv., 15 mA, with
1 mm. Al and 0 5 Cu filters; F.S.D. 50 cm.; dose rate: 55 R/minute).
Urethane treatment
Potentiation of radiation leukaemogenesis by urethane was carried out by
injecting the mice (1 hour before their exposure to X-rays) intraperitoneally with
a urethane solution in distilled water (1 mg./g. body weight).
Preparation and testing of leukaemogenic agent
The tissues taken from mice at different intervals after completion of the
irradiation, or from normal controls, were homogenized in 5 volumes ofphosphate
buffered saline (PBS) and the homogenate was centrifuged 3 times for 15 minutes
each at 10,000 x g; the final supernatant was passed through a Millipore filter
of 0 3 ,t mean pore size, and irradiated with 20,000 R (Rich, Seifert & Co. Dermo-
volt; physical conditions: 56 kv., 15 mA, with 0 5 mm. Al filter; F.S.D. 10 cm.;
dose rate: 750 R/minute). The leukaemogenic activity of the filtrate was tested
by injecting 0-07 ml. into a 5-7-day-old thymus graft implanted under the kidney
capsule of thymectomized, irradiated hosts, as previously described (Haran-Ghera.
1966). This method has been found to be more sensitive for testing the leukaemo-
genic activity of filtrates than is inoculation of the agent into newborns (Haran-
Ghera, Lieberman and Kaplan, 1966). Irradiation (550 R whole-body exposure)
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of the thymectomized host, essential in this testing system, could be carried out
without interfering with the induction ofleukaemia in the thymus graft implanted
under the kidney capsule, forthis siteofthymusgrafting, contraryto subcutaneous
implantation, prevents the repotentiation of leukaemogenesis in thymectomized,
irradiated C57B1 mice (Law, Bradley and Rose, 1963).
Testing of immunological reactivity following different irradiation procedures
The antigenic substance used was Shigella paradysenteriae. The strain of
bacteria was obtained through the courtesy ofDr. T. N. Harris, and was prepared
according to his description (Harris, Harris and Farber, 1954). A 10 per cent
suspension of the alcohol-killed bacteria in saline was used. Shigella antigen
was injected intraperitoneally in doses of 0-2 ml. of 0-1 per cent alcohol-killed
bacteria at different intervals after completion of irradiation, and the sera of
individual mice were collected 7 days thereafter and tested for antibodies to
Shigella. The agglutinins were measured in serial two-fold dilutions of 0.1 ml.
volume of mouse serum and a subsequent addition of 0-5 ml. of a 0-002 per cent
suspension of Shigella antigen in saline per tube. After shaking and incubation
at 370 C. for 1 hour, the tubes were stored at 4° C. for 48 hours, and then read for
macroscopic agglutination according to the pattern of sediment at the bottom of
the tubes.
RESULTS
Leukaemogenic activity offiltratesfrom pooled tissues ofirradiated donors
The mice received 4 weekly exposures of 170 R whole-body irradiation begun
at the age of 45 ± 5 days. Several tissues (thymus, bone marrow, spleen and
brain) were removed from the donors at 7, 15, 30 and 60 days after the last irradia-
tion, as well as from normal control mice, and cell-free filtrates were prepared and
tested for leukaemogenic activity.
The filtrate prepared from the pooled tissues taken from the irradiated donors
7 days after completion ofthe course ofirradiations showed 25 per cent leukaemo-
genic activity; all the other filtrates tested gave only borderline activity (Table I).
TABLE I.-Leulkaemogenic Activity of Filtrates from Irradiated Tissues (Bone
Marrow, Thymus, Spleen, Brain) Removed at Different Intervals Following
Irradiation.
Interval after Age at leukaemic
last irradiation Lymphatic leukaemia death
(170 R x 4) incidence (days)
7 days . . . 8/32=25% . 86; 106; 253; 277;
192; 177; 112; 148
15 days . . 2/26 = 7% . 160; 220
30 days . . . 2/22 = 9% . 194; 207
60 days . . . 1/17 = 6% . 198
Normal controls . 1/25 = 4% . 189
(70 days old)
Leukaemogenic activity offiltrates from the different tissues of irradiated or normal
donors
Several tissues (thymus, bone marrow, mesenteric lymph nodes, spleen and
plasma) were removed from 50-day-old normal mice and from irradiated mice
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2 or 7 days after termination of the X-ray treatment, and cell-free filtrates were
prepared. Cell-free filtrates were also prepared from thymus, bone marrow and
mesenteric lymph nodes of 400-day-old retired breeders.
Filtrates from normal thymus of young donors showed 10 per cent leukaemo-
genic activity, while the thymus filtrate from 400-day-old donors induced lym-
phomas in 17 per cent of the inoculated mice. Bone marrow filtrate from young
donors gave only borderline activity (6 per cent), while that from old mice was not
active. Plasma and spleen filtrates were inactive, whereas leukaemogenic activity
(12 per cent) in filtrates from mesenteric lymph nodes was demonstrable in old
mice only (Table II).
TABLE II.-Leulkaemogenic Activity ofFiltrates Preparedfrom
Different TissUes ofNornal and Irradiated C57B1 Mice
Donor tissue:
Normal controls
(50 days old)
I % leukaemia
0/20
4/41 =10%
. . 2/34=6%
1/30=3%
mph nodes . 0/30
1/40=2.5%
Ex-breeders
(400 days old)
3/18=17%
v . . O/19
,mph nodes . 3/24=12%
Average
latent
period
(days)
280
174
280
240
Irradiated-2 days after Irradiated-7 days after
last X-irradiation last X-irradiation
Average Average
latent latent
period period
% leukaemia (days) % leukaemia (days)
0/20 0/25
1/22=4.5% 200 1/29=3.5% 165
1/20=5% 160 7/30=23% 176
0/15 1/20=5% 200
0/18 1 /18=6% 320
1/35=3% 190
180
190
No leukaemogenic activity was detectable in the tissues removed from donors
2 days after the last exposure, whereas after 7 days, leukaemogenic activity was
found in 23 per cent of mice given the filtrate prepared from bone marrow. The
other filtrates tested were negative (Table II).
Transient depression of immunological responsiveness in mice at different intervals
after irradiation
Male and female C57B1/6 mice, 2-21 months old, were divided into 6 groups,
and given the following exposures to irradiation:
A. Four weekly doses of 170 R whole-body irradiation.
B. Thigh-shielding during each of 4 weekly exposures to 170 R, using a lead
strip of 5 mm. thickness.
C. Three weekly doses of 170 R whole-body irradiation, followed by thigh-
shielding during the fourth exposure to 170 R.
D. Intravenous injection of isologous bone marrow cells (2 x 107 nucleated
cells), 1-2 hours after each of 4 weekly whole-body exposures to 170 R.
31
Tissues tested
Plasma .
Thymus
Bone marrow
Spleen
Mesenteric ly1
PBS control
Thymus
Bone marrow
Mesenteric ly
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E. Intraperitoneal injection of urethane (1 mg./g. body weight) before each
of 4 weekly whole-body exposures to 170 R.
F. Mice anaesthetized with urethane (1 mg./g. body weight) before each of
4 weekly thigh-shielded exposures to 170 R.
G. Four weekly injections of urethane.
The irradiated and normal control mice were immunized with Shigella antigen
at intervals of 24 hours, 7, 14 or 21 days after completion ofthe irradiation treat-
ment; the sera were collected 7 days after inoculation, and testedfor agglutinating
antibody to Shigella.
As shown in Table III, the depressing effect ofsublethal doses of X-irradiation,
with or without urethane treatment, was transient, and recovery started at about
1 week after exposure. Antibody production in mice receiving 4 whole-body
exposures (group A) 7 days after the last exposure to X-rays was expressed in the
mean log2 titre of 4-7, as compared to 13*6 in the normal controls. The low titre
persisted for about 7 days after irradiation; thereafter a gradual increase was
noted, reaching normal values again of antibody production at about 30 days
after termination of the irradiation treatment. Bone marrow shielding during
each of the exposures to irradiation, or only during the last exposure (groups B
and C), or injection of bone marrow shortly thereafter (group D) (procedures
which reduced the leukaemia incidence), were found to similarly augment antibody
production in the irradiated mice-the mean log2 titre being 9-10 as compared to
13-14 in the matching normal controls (Table III).
The minimal antibody production was found in mice treated simultaneously
with X-rays and urethane (group E), with a mean log2 of 3*1, as compared to 11 in
mice treated with urethane alone (group G), and 4 7 in the corresponding irradiated
mice (group A). Urethane nullified the bone marrow shielding effect (group F),
causing a reduction in antibody production to a mean log2 titre of 2*8, compared
to 9 in the irradiated bone marrow shielded mice (group B).
Diminution ofprotective effect of bone marrow shielding
The mice used were female C57B1/6, 45 ± 5 days old. Treated animals received
3 weekly doses of 170 R each of whole-body irradiation, and a fourth, similar but
thigh-shielded exposure. They were then injected intravenously, at 1-2 hours
or 7 days after the last irradiation, with bone marrow (1I8 X 107 nucleated cells
in PBS) removed from isogenic donors 10 days after they received the last con-
current treatment of 4 weekly exposures to 170 R whole-body irradiation and ure-
thane (I mg./g. body weight, prepared as a 10 per cent solution in distilled water,
injected intraperitoneally shortly after each radiation exposure) (Haran-Ghera,
1966). The results are summarized in Table IV. The inhibition of radiation-
induced leukaemogenesis by bone marrow shielding was indicated by the low
incidence of leukaemia (25 per cent) in the group that received 3 weekly doses of
170 R each whole-body irradiation, and a fourth, similar but thigh-shielded
exposure (as compared with a 70 per cent incidence in mice treated similarly, but
without the shielding). Injection ofthe treated bone marrow shortly after irradia-
tion of the host did not alter the leukaemia incidence (17 per cent in group II),
whereas its administration 7 days thereafter increased the tumour incidence to
53 per cent (group III). No leukaemias developed in normal, non-irradiated mice
inoculated with similarly treated bone marrow.
734RADIATION IN LEUKAEMOGENESIS. I
600
r-
r-
0
-4
U0 '04
CO O
o~ o
m 4 _
Oa
b04 0 -.
o
49':
COo
22 o
62D
z.
. - 0
t0
CO'
6
10
e*
- CO sP -
o o o o
o tbt '0 e
4 Ci p,
_ -4 bf)~~P-
0
Q 0 Ct
I 4 C cO
I 0'\4 '0
_c _C 0
- P
'n "s 00 0 . 1
14O
0
10 0o
m
I o p,
0 I I In
CS P- 11
%^ 1^ -M &
0 100I
Co o
IW
10-
cq cq
0
x
r
54:
*,+'m+ me m X e
, ._ °- o o o o~
.
t- V. P I- r- P EZ
P
P4 V S
735
0
.4
75
e.
co
¢4c
1,
1,)
0-l
I.
.R U.
C.O .-NECHAMA HARAN-GHERA AND ALPHA PELED
TABLE IV.-Leulkaemia Development in Irradiated, Thigh-Shielded Mice Receiving
Bone Marrowfrom Donors Treated Concurrently with X-rays and Urethane
Average latent
Further treatment of Leukaemia period
irradiated host* incidence (days)
I. None . 4/16=25% 210
II. " Treated "t bone marrow, 2 hours 3/17=17% . 246
after irradiation of host
III. " Treated " bone marrow, 7 days 10/19=53% 226
after irradiation ofhost
* Irradiation of host: 170 R x 3 whole-body exposure plus 170 R x 1
thigh-shielded exposure.
t The bone marrow wasremovedfromisogenic donors treatedwith 4weekly
exposures of 170 R whole-body irradiation and urethane.
DISCUSSION
The present experiments confirm our previous observations (Haran-Ghera,
1966), demonstrating the " release " of a leukaemogenic agent in irradiated, non-
leukaemic tissues for a limited period ofabout 1 week after completion offraction-
ated irradiation. The results ofthe search for the leukaemogenic agent in different
tissues removed from the donors 2 or 7 days after completion of the irradiation
showed that the agent was only demonstrable 7 days after the irradiation, thus
suggesting the " eclipse " phenomenon described for the Rauscher virus (Rauscher,
1963). Most of the leukaemogenic activity demonstrable after 7 days was found
in the bone marrow. It has been shown that bone marrow cells repopulate the
irradiation-injured thymus (Ford and Micklem, 1963). The agent and/or trans-
formed cells could thus have reached the thymus during the period ofregeneration
via bone marrow cells, thereby increasing the concentration of agent in the target
organ. The assumption that the virus is in fact present in non-irradiated normal
C57B1 mice, and is probably transmitted from parents to offspring (Pollard and
Matsuzawa, 1964) is in accord with our findings of an occasional leukaemogenic
activity in filtrates prepared from normal tissues. These findings may explain
the observations of Rudali and Silberman (1965), who described leukaemogenic
activity in tissue grafts from various organs ofold, normal C57B1 mice.
Although the virus is apparently present, probably in low numbers, in normal
adult C57B1 mice, neoplasia does not develop unless they are exposed to radiation
(Kaplan, 1964), or to treatment with chemical carcinogens (Haran-Ghera, 1967).
Irradiation (Taliaferro, Taliaferro and Jaroslow, 1964) and chemical carcinogens
(Prehn, 1963) have been shown to cause transient and variable depression of im-
munological responsiveness, a condition that could contribute to the " release "
or " activation " of a latent virus. The present experiments indicate that the
doses of whole-body exposure to radiation used for leukaemia induction did in
fact cause a marked transient immunological depression, whereas the procedures
known to inhibit leukaemia development, e.g. bone marrow shielding during irra-
diation, or injection of bone marrow cells shortly after completion of the irradia-
tion, caused a rapid restoration of the immune response. Concurrent treatment
with urethane and irradiation, which has been shown to potentiateradiationleukae-
mogenesis (Kawamoto et al., 1958), increased the transient immunological depres-
sion when compared to radiation or urethane treatment alone. This increase in
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the immunological impairment may produce also an increase in the "release "
phenomenon, which would be in accord with the finding (Haran-Ghera, 1966)
of a more potent leukaemogenic agent when the filtrate is prepared from tissues
taken from donor mice treated concurrently with X-rays and urethane.
The minimal antibody production obtained in the mice anaesthetized with ure-
thane during the bone marrow shielded irradiation is in accord with the high inci-
dence of lymphoma development in such treated mice, and shows the injury effect
of urethane on bone marrow (which nullifies the action of bone marrow shielding),
as proposed by Haran-Ghera and Kaplan (1964).
The present experiments indicate that the maximal transient immunological
depression expressed in minimal antibody production persisted for about 7 days
after irradiation, coinciding with the limited time period in which most of the
leukaemogenic activity could be demonstrated in irradiated tissues.
The inhibition of radiation leukaemogenesis by the shielding of bone marrow
(Kaplan et al., 1953) or spleen (Lorenz, Congdon and Uphoff, 1953), or the injection
ofbone marrow or spleen cells (Kaplan et al., 1953), might be attributable to a rapid
restoration of the immune response, which may also affect the agent "release
"
phenomenon. Experimental support for such an assumption could be the observed
increase in the leukaemia incidence in irradiated, shielded mice when additional
leukaemogenic agent was injected after completion of the radiation treatment.
In this experiment we used as the leukaemic agent source "treated "bone marrow
taken from donor mice 10 days after concurrent treatment with X-rays and
urethane (a procedure shown to potentiate the activity of the leukaemogenic
agent (Haran-Ghera, 1966). The present results coincide with those obtained by
Duplan and Latarjet (1966), who showed an increase in the leukaemia incidence in
irradiated mice injected with bone marrow cells shortly after irradiation, followed
by injection of additional leukaemogenic extracts from radiation-induced lym-
phom-as.
SUMMARY
A leukaemogenic agent was demonstrated in non-leukaemic tissues ofirradiated
and normal C57B1 mice. Filtrates prepared from pooled tissues (thymus, bone
marrow, spleen and brain) removed from irradiated donors 7 days following irra-
diation, showed 25 per cent leukaemogenic activity; those removed 15, 30 and
60 days following irradiation, and from normal non-irradiated controls, gave only
borderline activity. When thymus, bone marrow, mesenteric lymph nodes,
spleen and plasma were tested separately for the active leukaemogenic agent, no
activity was demonstrable in the tissues removed from donors 2 days following
irradiation, whereas after 7 days, the bone marrow filtrate showed 23 per cent
leukaemogenic activity. The other filtrates tested were negative. The filtrate
from normal thymus of young donors showed 10 per cent leukaemogenic activity,
while the thymus filtrate from 400-day-old donors induced lymphomas in 17 per
cent of the inoculated mice. Bone marrow filtrates from young donors were
slightly active (6 per cent), while leukaemogenic activity in filtrates from mesen-
teric lymph nodes was demonstrable only in old mice (12 per cent).
A possible factor contributing to the " agent release " phenomenon demon-
strable for a limited time, could be the transient depression of immunological
responsiveness induced by irradiation. Tests on the immunological reactivity of
irradiated mice were performed by evaluating the production of antibodies to
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Shigella antigen. The 4 weekly doses of 170 R whole-body exposure, used for
leukaemia induction, resulted in marked immunological depression, the minimal
antibodyproduction in these mice persisting for about 1 weekfollowing irradiation,
and coinciding with the timing of the demonstration of " agent release ". It is
proposed that the degree ofimmunological depression ofthe host may be involved
in the amount of agent " released ".
The authors wish to thank Professor M. Feldman for his interest and advice
duringthis investigation, Professor D. Weiss forhis suggestions duringthe prepara-
tion ofthe manuscript, and Mr. S. Yecheskel and Mr. Z. Gadasi for their competent
technical assistance.
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